Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Statement regarding AutoStore

11 Mar 2022 08:01

RNS Number : 4880E
Ocado Group PLC
11 March 2022
Ā 

OCADO GROUP PLC

11 March 2022

Ā 

Ocado Group plc

ITC investigation over: conclusive victory for Ocado

ITC confirms all AutoStore cavity bot patents are invalid

On 10th March, the International Trade Commission, consisting of 5 experienced patent judges, decided in favour of Ocado on all points. Every patent AutoStore asserted in its ITC complaint was found either invalid or not infringed by Ocado's proprietary state of the art technology.

All of the 33 claims that originally constituted AutoStore's complaint to the ITC have now been rejected for a second time, or abandoned by AutoStore. AutoStore's key cavity bot patents, the UK versions of which are the only patents being asserted against Ocado in the High Court case starting next week, were all found to be invalid. A fourth, unrelated, patent was held not to be infringed.

Unusually, the ITC accepted review of the judge's original decision and in the same notice gave its decision on the merits, which further emphasises the strength of these findings.

Ocado continues actively to pursue its claims against AutoStore for infringement of Ocado's IP rights in both the United States and Europe, including its antitrust "Walker Process" claim against AutoStore in East Virginia and its infringement of five Ocado patents in New Hampshire. Ocado anticipates court determinations injuncting AutoStore and awarding Ocado damages for AutoStore's infringement of Ocado's patents.

An Ocado spokesperson said:

"We welcome the ITC's decision, which comprehensively confirms the judge's original findings last December. All 33 of the patent claims asserted against Ocado have now been confirmed for a second time to be either invalid or not infringed, demonstrating again how misguided AutoStore's complaint has been. The ITC investigation is now at its end.

Ā 

We expect further vindication in the High Court in London in the weeks ahead, where AutoStore has already abandoned half of the patents in the case."

Ā 

Contacts

ā— David Shriver, Director of Communications, Ocado Group plc, on 01707 228 000

ā— Martin Robinson at Tulchan Communications on 020 7353 4200

Ā 

Ā 

Ā 

Person responsible for arranging the release of this announcement:

Ā 

Neill Abrams

Group General Counsel & Company Secretary

Ocado Group plc

Buildings One & Two

Trident Place

Mosquito Way

Hatfield

Hertfordshire AL10 9UL

Fax: +44 (0)1707 227 997

email: company.secretary@ocado.com

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
STRFIFEDVAILLIF
Date   Source Headline
2nd Jun 20261:43 pmRNSDirector/PDMR Shareholding
1st Jun 20263:09 pmRNSTotal Voting Rights
29th May 20267:00 amRNSOcado Group & Asda to enter ecommerce partnership
28th May 20268:11 amRNSDirector Declaration
19th May 20269:26 amRNSDirector/PDMR Shareholding
19th May 20268:33 amRNSAdmission to Trading
1st May 202611:31 amRNSTotal Voting Rights
28th Apr 20263:53 pmRNSResult of AGM
20th Apr 202611:07 amRNSHolding(s) in Company
16th Apr 20264:05 pmRNSDirector/PDMR Shareholding
14th Apr 202611:25 amRNSAdmission to Trading
7th Apr 202612:54 pmRNSDirector/PDMR Shareholding
7th Apr 202610:51 amRNSHolding(s) in Company
1st Apr 202611:24 amRNSTotal Voting Rights
30th Mar 20263:54 pmRNSDirector/PDMR Shareholding
18th Mar 202610:22 amRNSHolding(s) in Company
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
5th Mar 202611:00 amRNSAnnual Financial Report and Notice of Meeting
3rd Mar 20262:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20262:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:57 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSPreliminary Results
17th Feb 20263:19 pmRNSDirector/PDMR Shareholding
5th Feb 20263:50 pmRNSHolding(s) in Company
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20268:29 amRNSHolding(s) in Company
3rd Feb 20266:09 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSDirector Declaration
2nd Feb 20264:40 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSUpdate on Sobeys Partnership
28th Jan 20264:26 pmRNSHolding(s) in Company
27th Jan 20264:57 pmRNSBlock Listing Interim Review
22nd Jan 20263:07 pmRNSHolding(s) in Company
20th Jan 20263:25 pmRNSHolding(s) in Company
16th Jan 20262:06 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:46 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSExclusivity with International Partners
30th Dec 20257:00 amRNSExclusivity with International Partners
23rd Dec 20254:03 pmRNSHolding(s) in Company
23rd Dec 20254:03 pmRNSHolding(s) in Company
16th Dec 202511:45 amRNSDirector/PDMR Shareholding
9th Dec 202510:23 amRNSRedemption of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.